Achieve 95%

Approved vaccination with third dose of Pfizer mRNA SARS-coV2 vaccine to adolescentsvaged 12 to 17 years; Immunocompromised persons who have received CoronaVac + CoronaVac Pfizer_BioNtech + Pfizer-BioNtech: Fifth dose of Pfizer mRNA platform vaccine to 6 months after last dose; Immunocompromised

The country must continue making efforts to complete the basic schedule plus a booster dose; Based on current national and international scientific and epidemiological evidence, a second booster dose is established 4 months after the application of the initial booster starting on Monday, April 4